摘要 |
<p>The present invention is related to a dry powder formulation containing tiotropium to be administed via inhalation, the use of said formulation in the treatment of respiratory diseases especially asthma and COPD (Chronic obstructive pulmonary disease), and the production process of said formulation.</p> |